Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

I01BX005051-01
Title: Development of new therapies for cancer and other diseases and conditions using analogs of growth hormone-releasing hormones (GHRH)
Principal Investigator:

Andrew V. Schally

Location: Miami, FL
Congressional District Code: 24
Research Service: Biomedical Laboratory R&D
Project Period: April 2020 - March 2024
FY 2021 Funding Amount: $990,934
Total Award Amount
(all years):
$3,994,769
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER


Excerpt:

In view of documented activities and potential extensive applications of the antagonistic and agonistic analogs of growth hormone-releasing hormone (GHRH) in various areas of medicine, including the treatment of cancer, infarcted heart, diabetes, wounds and eye diseases, these projects will continue. Our main goal will be further development of analogs of GHRH, which appear to be free of side effects. Newly synthesized antagonists of growth hormone-releasing hormone (GHRH) of AVR class with high...



Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.